Research study Program year 2020 Source: CMS Open Payments

Enabling Innovative Respiratory Real World Evidence Generation: Sensor

Research payments

$943,594

9 payments

Through program year 2020, $943,594 in research payments was reported against Enabling Innovative Respiratory Real World Evidence Generation: Sensor, across 9 payments, paid by GlaxoSmithKline, LLC..

Paid by: GlaxoSmithKline, LLC.
ClinicalTrials.gov: No trial number was reported for this study

By program year

2 rows

Year	Kind	Amount	Payments
2020	Research	$207,653	2
2019	Research	$735,942	7

Breakdown

Who paid Research payments · program years 2019–2020

GlaxoSmithKline, LLC. $943,594 9 payments

Who received the money Research payments · program years 2019–2020

Geisinger Clinic Organisation paid for research $943,594 9 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

1 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

Paul Simonelli Danville, PA Named on 9 payments

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.